We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener

Session

Lower GI (colon, rectum, anus)
6012
Digital Poster
Clinical
Image-based deep learning model for predicting pathological response in rectal cancer using post-chemoradiotherapy magnetic resonance imaging
JAE-SUNG KIM, Korea Republic of
PO-1242
Is there a role for perioperative radiotherapy in surgically resected stage IV rectal cancer?
Jeanny Kwon, Korea Republic of
PO-1243
Severe surgical morbidity after chemoradiotherapy conformational-3D versus IMRT for rectal cancer
Maëlle Martin, France
PO-1244
Prediction of response to neo-adjuvant chemoradiotherapy using radiomics in rectal cancer
François Lucia, France
PO-1246
Radiochemotherapy in anal cancer, what is the optimal dose? A single istitutional experience
Noemi Giannini, Italy
PO-1247
Preoperative radiotherapy with Intensity-Modulated SIB for rectal cancer: a systematic review
Alessia Surgo, Italy
PO-1248
Lateral Pelvic Nodal Boost During Short Course Radiation Therapy for Locally Advanced Rectal Cancer
Comron Hassanzadeh, USA
PO-1249
The utility of short-course radiotherapy (SCRT) for watch-and-wait strategy (w&w) in rectal cancer
Karol Paciorek, Poland
PO-1250
Upfront surgery vs. neoadjuvant chemoradiation in upper rectal cancers
Reena Engineer, India
PO-1251
Chemoradiation for anal cancer: correlation of hematologic toxicity and dose to pelvic bone marrow.
Eleonora Ferrara, Italy
PO-1252
Influence of radiation treatment technique on outcome and toxicity in anal cancer.
MARIA CARMEN FERNANDEZ FERNANDEZ, Spain
PO-1253
Watch and wait strategy for rectal cancer : preliminary results
Véronique Vendrely, France
PO-1254
prospective study of safety and response in moderately hypofractionated chemoradiation rectal cancer
DIVYA G R, India
PO-1255
Local excision followed by radiotherapy or chemoradiotherapy for early stage rectal adenocarcinoma.
Sofia Santana Jimenez, Spain
PO-1256
A radiomic signature model to predict chemoradiation-induced change in CD8+ cells in rectal cancer
Yu Jin Lim, Korea Republic of
PO-1257
Pragmatic and effective use of short course radiotherapy for stage IV rectal cancer
Martin Higgins, Ireland
PO-1258
Increased SII and low Hb level are associated with poor OS in rectal cancer after preoperative CRT
Yi-En Lin, Taiwan
PO-1259
Neutrophil and platelet-to-lymphocyte ratio as prognostic factors in locally advanced rectal cancer
VICTOR DUQUE-SANTANA, Spain
PO-1260
Predictive model of 2yDFS during MR guided RT neoadjuvant chemoradiotherapy in LARC patients
Giuditta Chiloiro, Italy
PO-1261
Outcomes in locally recurrent rectal cancer treated with reirradiation stereotactic ablative radiotherapy (SABR)
Rebecca Muirhead, United Kingdom
PO-1262
Exclusive radiotherapy in early stage anal cancer - outcomes, patterns and predictors of relapse
Aurélien Briens, France
PO-1263
Predictive factors of pathological response to neoadjuvant chemoradiotherapy in rectal cancer
pasquale trecca, Italy
PO-1264
Neoadjuvant rectal and Clavien-Dindo scores in Locally Advanced Rectal Cancer
Marta Montero Feijoo, Spain
PO-1265
Induction chemotherapy in bulky HPV-negative anal canal cancer
Francesca De Felice, Italy
PO-1266
Using decision tree methodology to predict overall survival in locally advanced rectal cancer
Francesca De Felice, Italy
PO-1267
Predicting the benefit of stereotactic body radiotherapy of colorectal cancer metastases
Sara Lindberg, Sweden
PO-1268
C-Reactive Protein as predictive factor for response to chemoradiotherapy in Rectal Cancer
Fátima Aurora Lima Aires, Portugal
PO-1269
Neoadjuvant short-course hyperfractionated accelerated radiotherapy for rectal cancer
Hiroshi Doi, Japan
PO-1270
Dose-escalated pencil beam proton therapy for reirradiation of pelvic recurrences from rectal cancer
Camilla Kronborg, Denmark
PO-1271
Volumetric Modulated Arc Therapy with Simultaneous Integrated Boost in Carcinoma of the Anal Canal
Letizia Deantonio, Switzerland
PO-1272
Title: Impact of HPV infection in anal carcinoma patients treated with definitive chemo-radiation
ILAN DANIEL PERROT ROSENBERG, Chile
PO-1273
Impact of pretreatment anemia in patients with rectal cancer treated with chemoradiotherapy
Rita Marina Niespolo, Italy
PO-1274
Potential for Isotoxic Re-Irradiation SABR in Locally Recurrent Rectal Cancer
Maxwell Robinson, United Kingdom
PO-1275
Differential Response of FDG Uptake in Pelvic Bone Marrow to Concurrent Chemoradiotherapy
Maxwell Robinson, United Kingdom
PO-1276
Practice of Radiation Therapy for Anal Cancer in Austria –A Survey on behalf of the ÖGRO-GIT
Sabine Gerum, Austria
PO-1277